Heart risk study in pregnant women with heart defects pulled before start
NCT ID NCT06678256
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to check if blood tests taken during and after pregnancy could help predict future heart problems in women with adult congenital heart disease. The goal was to see if changes in these tests over time gave better warnings than a single test. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- A website designed to steer teens with heart defects away from vaping
- AI stethoscope aims to spot hidden heart and lung problems in children
- Can community hospitals in zambia master severe disease care?
- App-Based exercise program aims to strengthen hearts in congenital disease
- Which nerve block eases Children's heart surgery pain better?